deListed Australia

SEARCH LISTED COMPANY

ANY AUS OR NZ COMPANY

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived funds or use SEARCH

SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BENITEC BIOPHARMA LIMITED(BLT)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
BENITEC LIMITED30/04/200225/11/2011
QUEENSLAND OPALS NL30/04/2002

Shareholder links

Our website ranking of BLT: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000BLT8
Address: Level 14, 114 William St Melbourne VIC 3000 Australia
Tel:  +61 (03) 8692-7222 Fax: +61 (03) 9966-9923

Date first listed: 17/02/1997
Company Secretary: 
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology, research and development.

News & Events

Expand this box to read and print

delisted from the close of trading on Thursday, 16 April 2020 pursuant to Listing rule 17.11.

16/04/2020

we understand the company changed its domicile from Australia to the United States with Benitec Biopharma Inc acquiring all the shares in BLT and issuing one share in Benitec Biopharma Inc for every 300 BLT shares - Benitec Biopharma Inc will trade on Nasdaq under the symbol BNTC

16/04/2020

The previously announced scheme of arrangement to redomicile from Australia to the United States has been fully implemented today. The redomiciliation was approved by Benitec shareholders at a Scheme Meeting held on 26 March 2020, and approved by the Supreme Court of Queensland on 30 March 2020. Benitec Biopharma is now the sole shareholder in the company and is the ultimate parent company of the group.

15/04/2020

Formal notice was given by the company to NASDAQ on April 2, 2020 (Pacific Time) of the intention to voluntarily delist the company's listed warrants from the NASDAQ Capital Market in connection with the completion of the scheme of arrangement to re-domicile the Benitec group from Australia to the United States of America.

03/04/2020

The Foreign Investment Review Board has now confirmed that the new changes to the foreign investment regime do not apply to agreements entered into prior to 10.30pm (AEDT) on 29 March 2020. As the Company and Benitec Biopharma Inc. entered into the Amended and Restated Scheme Implementation Agreement on 30 January 2020, US Holdco will not be required to notify FIRB in respect of the scheme of arrangement.

31/03/2020

The securities of Benitec Biopharma Limited will be suspended from quotation immediately under Listing Rule 17.2, following lodgement of the Supreme Court of Queensland orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which Benitec Biopharma Inc. will acquire all of the issued shares in BLT.

30/03/2020

we understand that on or about this date the company consolidated its shares 1 for 25

19/07/2013

The suspension of trading in the securities of Benitec Biopharma Limited will be lifted immediately, following receipt of an announcement in relation to the completion of a capital raising.

06/06/2013

The securities of Benitec Biopharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, in accordance with listing rule 17.2, pending the release of an announcement by the Company in relation to the completion of a proposed capital raising. Security Code: BLT

05/06/2013

The suspension of trading in the securities of Benitec Biopharma Limited (the "Company") will be lifted immediately, following receipt of an announcement in relation to the completion of a capital raising. Security Code: BLT

05/03/2013

Benitec Biopharma Limited (ASX:BLT) advises that the proposed capital raising is not yet finalised and as a result the voluntary suspension will remain in place pending a further announcement on or before Tuesday 5 March 2013 regarding the outcome of the capital raising.

28/02/2013

The securities of Benitec Biopharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, in accordance with listing rule 17.2, pending the release of an announcement by the Company in relation to the completion of a proposed capital raising. Security Code: BLTThe securities of Benitec Biopharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, in accordance with listing rule 17.2, pending the release of an announcement by the Company in relation to the completion of a proposed capital raising. Security Code: BLT

27/02/2013

name changed from Benitec Limited

25/11/2011

ASX Announcements (courtesy of ASX)

 

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
 Most recent comments

What happened to my shares in Benitec after they delisted.??

27/07/2022 17:11:50

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    27/03/2020Peter Francis875,000$0.031$27,158.00
    28/05/2018Megan Boston100,000$0.171$17,056.00
    30/01/2015John Chiplin-63,020$0.720$45,500.00
    05/03/2014Peter French9,939$2.012$19,996.00

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Jerel BanksExecutive Chairman26/10/2016
    Peter FrancisNon Exec Chairman08/02/2006
    Cliff HollowayCOO24/08/2016
    Bryan DulhuntyCFO01/07/2016
    Kevin BuchiNon Exec Director11/04/2013
    Megan BostonExecutive Director16/08/2016
    Edward SmithDirector15/04/2020
    Oliver KiddCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.